
Approved for the treatment of advanced zzso cell zzso by the US zzso and other regulatory agencies, zzso is an agent with multiple targets that may also prove beneficial in other zzso Phase III trials are zzso in melanoma, zzso zzso and zzso lung zzso zzso of the Phase II data and zzso studies conducted in that context suggests that zzso of zzso and signaling in tumor cells may play a part in the clinical efficacy of zzso Although the vascular zzso growth factor zzso zzso are the most populated class of targeted agents in cancer clinical trials, zzso may prove to have unique properties that distinguish zzso A detailed discussion of the clinical trials in zzso cell zzso melanoma and zzso zzso highlights what is known and what has yet to be understood about this zzso 

